NAV10/13/2017 Chg.-0.3500 Type of yield Investment Focus Investment company
575.7300EUR -0.06% reinvestment Equity Worldwide Bellevue Asset Mgmt. 

Monthly performance

  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2009 - - - - -2.45 6.30 6.58 -0.94 3.24 -11.67 4.98 5.10 -
2010 4.70 4.84 5.87 0.14 -4.99 -3.21 -3.09 0.49 4.34 4.57 1.80 4.34 +20.78%
2011 -4.93 -0.52 -1.71 3.48 3.28 -1.57 -1.16 -13.41 -0.17 1.99 4.08 6.82 -5.27%
2012 12.52 -0.44 3.83 1.03 6.49 1.14 7.03 -0.33 3.59 -9.18 4.64 -1.86 +30.44%
2013 4.47 5.61 9.77 6.55 4.77 -4.15 12.35 -2.03 6.33 -3.56 8.10 -0.15 +57.85%
2014 12.43 4.14 -10.65 -4.57 4.54 8.21 1.21 13.15 3.08 11.08 3.16 2.38 +56.40%
2015 15.76 6.41 5.03 -7.83 12.31 -1.95 2.94 -12.77 -11.98 10.68 7.11 -1.84 +20.78%
2016 -22.77 -5.53 -0.31 3.53 6.38 -9.16 12.51 -2.37 2.05 -11.83 12.41 -3.35 -21.86%
2017 4.94 9.09 -1.11 -0.06 -6.83 6.01 -0.54 3.80 -0.35 0.85 - - -

Calculated values

  YTD 6 Months 1 Year 3 Years 5 Years
Volatility 19.10% 18.53% 23.40% 29.68% 27.23%
Sharpe ratio 1.12 0.49 0.76 0.39 0.78
Best month +9.09% +6.01% +12.41% +15.76% +15.76%
Worst month -6.83% -6.83% -11.83% -22.77% -22.77%
Maximum loss -10.90% -10.90% -11.67% -44.14% -44.14%
Outperformance -7.35% - -5.79% -6.29% -1.48%
 
All quotes in EUR

Tranches

Name   Type of yield Repurchase p. 1 Year 3 Years
BB Adamant Biotech I USD reinvestment 508.7700 +26.05% +28.63%
BB Adamant Biotech I EUR reinvestment 575.7300 +17.47% +37.67%
BB Adamant Biotech I CHF reinvestment 436.9700 +24.30% +31.49%
BB Adamant Biotech I GBP reinvestment 404.1200 +11.27% -
BB Adamant Biotech B USD reinvestment 477.5600 +25.13% +25.81%
BB Adamant Biotech B CHF reinvestment 407.9500 +23.39% +28.61%
BB Adamant Biotech B EUR reinvestment 538.4200 +16.62% +34.66%

Performance

YTD  
+15.95%
6 Months  
+4.17%
1 Year  
+17.47%
3 Years  
+37.67%
5 Years  
+156.72%
Since start  
+360.58%
Year
2016
  -21.86%
2015  
+20.78%
2014  
+56.40%
2013  
+57.85%
2012  
+30.44%
2011
  -5.27%
2010  
+20.78%